Selpercatinib (Retevmo): A Breakthrough Cancer Therapy What is Selpercatinib (Retevmo)? Selpercatinib, supplied as 40 mg and 80 mg capsules for oral use under the brand name Retevmo, is a targeted

Ustekinumab (Stelara): Medication Guide Introduction Ustekinumab, marketed under the brand name Stelara, is a monoclonal antibody. Monoclonal antibodies are specific proteins that identify and bind